163 related articles for article (PubMed ID: 29178896)
1. Estimating the value of point-of-care HPV testing in three low- and middle-income countries: a modeling study.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
BMC Cancer; 2017 Nov; 17(1):791. PubMed ID: 29178896
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.
Campos NG; Castle PE; Wright TC; Kim JJ
Int J Cancer; 2015 Nov; 137(9):2208-19. PubMed ID: 25943074
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of an HPV self-collection campaign in Uganda: comparing models for delivery of cervical cancer screening in a low-income setting.
Campos NG; Tsu V; Jeronimo J; Njama-Meya D; Mvundura M; Kim JJ
Health Policy Plan; 2017 Sep; 32(7):956-968. PubMed ID: 28369405
[TBL] [Abstract][Full Text] [Related]
4. To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Lee K; Kim JJ
Int J Cancer; 2017 Mar; 140(6):1293-1305. PubMed ID: 27925175
[TBL] [Abstract][Full Text] [Related]
5. Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis.
Campos NG; Tsu V; Jeronimo J; Regan C; Resch S; Clark A; Sy S; Kim JJ
Int J Cancer; 2019 Feb; 144(4):687-696. PubMed ID: 30132850
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based policy choices for efficient and equitable cervical cancer screening programs in low-resource settings.
Campos NG; Tsu V; Jeronimo J; Mvundura M; Kim JJ
Cancer Med; 2017 Aug; 6(8):2008-2014. PubMed ID: 28707435
[TBL] [Abstract][Full Text] [Related]
7. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial.
Mezei AK; Pedersen HN; Sy S; Regan C; Mitchell-Foster SM; Byamugisha J; Sekikubo M; Armstrong H; Rawat A; Singer J; Ogilvie GS; Kim JJ; Campos NG
BMJ Open; 2018 Jun; 8(6):e020484. PubMed ID: 29895648
[TBL] [Abstract][Full Text] [Related]
8. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
Sharma M; Seoud M; Kim JJ
Vaccine; 2017 Jan; 35(4):564-569. PubMed ID: 28017434
[TBL] [Abstract][Full Text] [Related]
10. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
12. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
[TBL] [Abstract][Full Text] [Related]
13. The Cost-Effectiveness of Visual Triage of Human Papillomavirus-Positive Women in Three Low- and Middle-Income Countries.
Campos NG; Jeronimo J; Tsu V; Castle PE; Mvundura M; Kim JJ
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1500-1510. PubMed ID: 28710075
[No Abstract] [Full Text] [Related]
14. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
15. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
16. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras.
Aguilar IB; Mendoza LO; García O; Díaz I; Figueroa J; Duarte RM; Perdomo G; Garcia AG; Janusz CB
Vaccine; 2015 May; 33 Suppl 1():A167-73. PubMed ID: 25919157
[TBL] [Abstract][Full Text] [Related]
18. The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
Campos NG; Sharma M; Clark A; Lee K; Geng F; Regan C; Kim J; Resch S
Int J Gynaecol Obstet; 2017 Jul; 138 Suppl 1():47-56. PubMed ID: 28691334
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of cervical-cancer screening in five developing countries.
Goldie SJ; Gaffikin L; Goldhaber-Fiebert JD; Gordillo-Tobar A; Levin C; Mahé C; Wright TC;
N Engl J Med; 2005 Nov; 353(20):2158-68. PubMed ID: 16291985
[TBL] [Abstract][Full Text] [Related]
20. The value of improving failures within a cervical cancer screening program: an example from Norway.
Burger EA; Kim JJ
Int J Cancer; 2014 Oct; 135(8):1931-9. PubMed ID: 24615416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
